Kovack Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
618
-4
| -0.6% | -$1.56K | 0.02% | 515 |
|
|
2025
Q1 | $270K | Sell |
622
-21
| -3% | -$9.13K | 0.03% | 455 |
|
|
2024
Q4 | $237K | Buy |
643
+157
| +32% | +$57.9K | 0.02% | 527 |
|
|
2024
Q3 | $253K | Buy |
486
+43
| +10% | +$22.4K | 0.03% | 485 |
|
|
2024
Q2 | $240K | Sell |
443
-42
| -9% | -$22.8K | 0.03% | 475 |
|
|
2024
Q1 | $251K | Buy |
485
+11
| +2% | +$5.7K | 0.03% | 392 |
|
|
2023
Q4 | $223K | Buy |
+474
| New | +$223K | 0.03% | 492 |
|
|
2023
Q3 | – | Sell |
-799
| Closed | -$355K | – | 562 |
|
|
2023
Q2 | $355K | Buy |
799
+278
| +53% | +$124K | 0.05% | 370 |
|
|
2023
Q1 | $239K | Buy |
521
+4
| +0.8% | +$1.84K | 0.03% | 469 |
|
|
2022
Q4 | $265K | Sell |
517
-139
| -21% | -$71.3K | 0.04% | 433 |
|
|
2022
Q3 | $298K | Buy |
+656
| New | +$298K | 0.04% | 408 |
|
|
2022
Q2 | – | Sell |
-568
| Closed | -$278K | – | 611 |
|
|
2022
Q1 | $278K | Sell |
568
-461
| -45% | -$226K | 0.03% | 550 |
|
|
2021
Q4 | $477K | Buy |
1,029
+46
| +5% | +$21.3K | 0.05% | 395 |
|
|
2021
Q3 | $366K | Buy |
983
+15
| +2% | +$5.59K | 0.04% | 458 |
|
|
2021
Q2 | $370K | Sell |
968
-3
| -0.3% | -$1.15K | 0.04% | 440 |
|
|
2021
Q1 | $348K | Buy |
971
+163
| +20% | +$58.4K | 0.05% | 404 |
|
|
2020
Q4 | $259K | Buy |
808
+43
| +6% | +$13.8K | 0.04% | 449 |
|
|
2020
Q3 | $205K | Buy |
+765
| New | +$205K | 0.04% | 415 |
|
|
2020
Q1 | – | Sell |
-665
| Closed | -$201K | – | 476 |
|
|
2019
Q4 | $201K | Buy |
+665
| New | +$201K | 0.04% | 461 |
|
|
2019
Q1 | – | Sell |
-779
| Closed | -$205K | – | 433 |
|
|
2018
Q4 | $205K | Buy |
+779
| New | +$205K | 0.06% | 340 |
|